These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36782321)

  • 21. Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.
    Pleuhs B; Mistler CB; Quinn KG; Dickson-Gomez J; Walsh JL; Petroll AE; John SA
    J Prim Care Community Health; 2022; 13():21501319211063999. PubMed ID: 35068243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018.
    McFarland W; Lin J; Santos GM; Arayasirikul S; Raymond HF; Wilson E
    AIDS Behav; 2020 May; 24(5):1290-1293. PubMed ID: 31563984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.
    Walters SM; Frank D; Van Ham B; Jaiswal J; Muncan B; Earnshaw V; Schneider J; Friedman SR; Ompad DC
    AIDS Behav; 2022 Apr; 26(4):1308-1320. PubMed ID: 34626265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Pre-exposure Prophylaxis Among People Who Inject Drugs: Exploratory Findings of the Interaction Between Race, Homelessness, and Trust.
    Zhou X; Altice FL; Chandra D; Didomizio E; Copenhaver MM; Shrestha R
    AIDS Behav; 2021 Nov; 25(11):3743-3753. PubMed ID: 33751313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States.
    Carter G; Meyerson B; Rivers P; Crosby R; Lawrence C; Cope SD; DeBruicker D; Levin S; Meeks W; Thomas C; Turner B; Abert C; Coles H; Allen A; Gonzalez-Fagoaga E; Grivois-Shah R
    AIDS Behav; 2021 Oct; 25(10):3085-3096. PubMed ID: 34003385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022.
    Suprasert B; Tate M; Reagan D; Ruiz R; Gao K; McNaughton K; Miller K; Marr A; Taylor KD; Wilson EC; McFarland W
    AIDS Behav; 2024 Jun; 28(6):2089-2100. PubMed ID: 38526638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study.
    Jacka BP; Nolen S; Bessey SE; Zang X; Goedel WC; Yedinak JL; Marshall BDL
    J Acquir Immune Defic Syndr; 2022 Dec; 91(5):449-452. PubMed ID: 36150038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs-Cabell County, West Virginia, 2019.
    Furukawa NW; Weimer M; Willenburg KS; Kilkenny ME; Atkins AD; Paul McClung R; Hansen Z; Napier K; Handanagic S; Carnes NA; Kemp Rinderle J; Neblett-Fanfair R; Oster AM; Smith DK
    Public Health Rep; 2022; 137(1):25-31. PubMed ID: 33646890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings.
    King AR; Shah S; Randall LA; Frew PM; Spaulding A; ; Holloway IW
    BMC Infect Dis; 2022 Sep; 22(1):737. PubMed ID: 36104676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.
    Walters SM; Kral AH; Simpson KA; Wenger L; Bluthenthal RN
    Subst Use Misuse; 2020; 55(14):2409-2419. PubMed ID: 32962490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon.
    Spencer HC; Babiarz J; Menza TW
    Int J STD AIDS; 2023 Jul; 34(8):567-573. PubMed ID: 36949570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic during a Local HIV Outbreak at the Onset of the COVID-19 Pandemic.
    Braun HM; Walter C; Farrell N; Biello KB; Taylor JL
    J Addict Med; 2022 Nov-Dec 01; 16(6):678-683. PubMed ID: 36383918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya.
    Bazzi AR; Yotebieng KA; Agot K; Rota G; Syvertsen JL
    AIDS Care; 2018 Mar; 30(3):343-346. PubMed ID: 28780885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying the Behavioral Model for Vulnerable Populations to Pre-Exposure Prophylaxis Initiation Among Women Who Inject Drugs.
    Felsher M; Bellamy S; Piecara B; Van Der Pol B; Laurano R; Roth AM
    AIDS Educ Prev; 2020 Dec; 32(6):486-492. PubMed ID: 33779207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
    Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
    BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs.
    Picard J; Jacka B; Høj S; Laverdière É; Cox J; Roy É; Bruneau J
    AIDS Behav; 2020 Aug; 24(8):2400-2408. PubMed ID: 31997057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs.
    Harris MT; Weinberger E; O'Brien C; Althoff M; Paltrow-Krulwich S; Taylor JL; Judge A; Samet JH; Walley AY; Gunn CM
    Addict Sci Clin Pract; 2024 Jun; 19(1):47. PubMed ID: 38831359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PrEP disclosure and discussions within social networks of people who inject drugs experiencing homelessness: a brief report.
    Shaw LC; Biello KB; Vahey S; Brody JK; Bazzi AR
    BMC Public Health; 2023 Feb; 23(1):263. PubMed ID: 36750814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation.
    Rosen JG; Zhang L; Pelaez D; Park JN; Glick JL
    AIDS Behav; 2023 Jul; 27(7):2440-2453. PubMed ID: 36596866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.